维普期刊资源整合服务平台（V6.5）

439篇 您的检索式：作者名="YATABE T"

选中清除导出查看参考文献查看引证文献引用追踪共22页首页上一页第1页下一页末页 /22 跳转

	题名	作者	年代	出处	被引量
1	Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers,specifically in adenocarcinomas 显示文摘	Hida T Yatabe Y Achiwa H	1998	Cancer Res1998，58，：	1
2	Solitary fibrous tumour: significance of p53 and CD34 immunoreactivity in its mahgnant transformation显示文摘	Yokoi T Tsuzuki T Yatabe Y etal	1998	Histopathology1998，32，5：	1
3	Preoperative carbohydrate-rich beverage reduces hypothermia during general anesthesia in rats显示文摘	Yatabe T Kawano T Yamashita K	2011	J Anesth2011，25，4：	1
4	Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405) : an open label, randomised phase 3 trial 显示文摘	Mitsudomi T Morita S Yatabe Y	2010	Lancet Oncol2010，11，2：	1
5	EGFR and HER2 genomic gain in recurrent non - small cell lung cancer after surgery : impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort 显示文摘	Varella - Garcia M Mitsudomi T Yatabe Y	2009	J Thorac Oncol2009，4，3：	1
6	Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor ( WJTOG3405 ) : an open label, randomised phase 3 trial 显示文摘	Mitsudomi T Morita S Yatabe Y	2010	Lancet Oncol2010，11，2：	1
7	Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405):an open label,randomised phase 3 trial显示文摘	Mitsudomi T Morita S Yatabe Y		0，，02：	1
8	Increased expression of cyclooxygenase2 occurs frequently in human lung cancers,specially in adenocarcinomas显示文摘	Hida T Yatabe Y Achiwa H	1998	Cancer Res1998，58，17：	1
9	Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): An open label, randomized phase 3 trial显示文摘	Mitsudomi T Morita S Yatabe Y	2010	Lancet Oncology2010，11，2：	1
10	Biological and clinical implications of EGFR mutations in lung cancer显示文摘	Mitsudomi T Kosaka T Yatabe Y		0，，03：	1
11	TDT-1 expression in pulmonary adenocarcinomas显示文摘	Yatabe Y Mitsudomi T Takahashi T	2002	Surg Pathol2002，26，6：	1
12	Increased expression of cax-2 in the development of human lung cancers显示文摘	Kozaki K Yatabe Y	2002	J Environ Pathol Toxicol 0ncol2002，21，2：	1
13	Increased expression of COX-2 in the development of human lung cancers 显示文摘	Takahashi T Kozaki K Yatabe Y	2002	J Environ Pathol Toxicol Oncol2002，21，2：	1
14	Increased expression of cydooxygenase- 2 occurs frequently in human lung cancers,specifically in adenocarcinomas显示文摘	Hida T Yatabe Y Achiwa H	1998	Cancer Res1998，58，12：	1
15	EGFR mutation is specific for terminal respiratory unit type adenocarcinoma 显示文摘	Yatabe Y Kosaka T Takahashi T	2005	Am J Surg Pathol2005，29，5：	1
16	Gefitinib versus cisplatin plus docetaxel in patient with non small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405) : an open label, randomised phase 3 trial显示文摘	Mitsudomi T Morita S Yatabe Y	2010	Lancet Oncol2010，11，2：	1
17	Mutations of the epidermal growth factor receptor or gene in lung cancer: Biological and clinical implications 显示文摘	Kosaka T Yatabe Y Endo H Kuwano H Takahashi T Mitsudomi T	2004	Cancer Res2004，64，24：	1
18	Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib显示文摘	KOSAKA T YATABE Y ENDOH H	2006	Clin Cancer Res2006，12，19：	1
19	Preoperative fluid management contributesto the prevention of intraoperative hypothennia显示文摘	Yatabe T Yokoyama M	2011	Masui2011，60，7：	1
20	TTF-1 expression in pul-monary adenocarcinomas显示文摘	Yatabe Y Mitsudomi T Takahashi T	2002	Am J Surg Pathol2002，26，6：	1

返回顶部每页显示：

共22页首页上一页第1页下一页末页 /22 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示